Literature DB >> 10688901

The B cell-restricted adaptor BASH is required for normal development and antigen receptor-mediated activation of B cells.

K Hayashi1, R Nittono, N Okamoto, S Tsuji, Y Hara, R Goitsuka, D Kitamura.   

Abstract

B cell antigen receptor signals development, activation, proliferation, or apoptosis of B cells depending on their condition, and its proper signaling is critical for activation and homeostasis of the immune system. The B cell-restricted adaptor protein BASH (also termed BLNK/SLP-65) is rapidly phosphorylated by the tyrosine kinase Syk after BCR ligation and binds to various signaling proteins. BASH structurally resembles SLP-76, which is essential for T cell development and T cell receptor signaling. To evaluate the role for BASH in B cell development and function in vivo, we disrupted BASH alleles in embryonic stem cells by means of homologous recombination and used these cells to complement lymphocyte-incompetent blastocysts from RAG2-deficient mice. In the resultant chimeric mice, T cell development was apparently normal, but B cell development was impaired, and a normally rare population of large preB cells expressing preB cell receptor dominated in the bone marrow in place of small preB cells, although they were mostly noncycling. In addition, the mature B cell populations in the periphery and the bone marrow profoundly decreased in size, as did B-1 cells in the peritoneal cavity, and serum Ig was severely reduced. The BASH-deficient B cells scarcely proliferated or up-regulated B7-2 in response to BCR ligation and poorly proliferated upon CD40 ligation or lipopolysaccharide stimulation. This phenotype indicates that BASH is critical for preB cell receptor signaling inducing proliferation of large preB cells and the following differentiation, for peripheral B cell maturation, and for BCR signaling inducing activation/proliferation of B cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10688901      PMCID: PMC16002          DOI: 10.1073/pnas.040575697

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

1.  In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death.

Authors:  K P Lam; R Kühn; K Rajewsky
Journal:  Cell       Date:  1997-09-19       Impact factor: 41.582

2.  Identification of two tyrosine phosphoproteins, pp70 and pp68, which interact with phospholipase Cgamma, Grb2, and Vav after B cell antigen receptor activation.

Authors:  C Fu; A C Chan
Journal:  J Biol Chem       Date:  1997-10-24       Impact factor: 5.157

Review 3.  The complexity of signaling pathways activated by the BCR.

Authors:  A L DeFranco
Journal:  Curr Opin Immunol       Date:  1997-06       Impact factor: 7.486

4.  BLNK: a central linker protein in B cell activation.

Authors:  C Fu; C W Turck; T Kurosaki; A C Chan
Journal:  Immunity       Date:  1998-07       Impact factor: 31.745

Review 5.  Adaptor proteins in lymphocyte antigen-receptor signaling.

Authors:  E J Peterson; J L Clements; N Fang; G A Koretzky
Journal:  Curr Opin Immunol       Date:  1998-06       Impact factor: 7.486

6.  Requirement for B cell linker protein (BLNK) in B cell development.

Authors:  R Pappu; A M Cheng; B Li; Q Gong; C Chiu; N Griffin; M White; B P Sleckman; A C Chan
Journal:  Science       Date:  1999-12-03       Impact factor: 47.728

7.  Efficient production of Cre-mediated site-directed recombinants through the utilization of the puromycin resistance gene, pac: a transient gene-integration marker for ES cells.

Authors:  M Taniguchi; M Sanbo; S Watanabe; I Naruse; M Mishina; T Yagi
Journal:  Nucleic Acids Res       Date:  1998-01-15       Impact factor: 16.971

8.  Btk/Tec kinases regulate sustained increases in intracellular Ca2+ following B-cell receptor activation.

Authors:  A C Fluckiger; Z Li; R M Kato; M I Wahl; H D Ochs; R Longnecker; J P Kinet; O N Witte; A M Scharenberg; D J Rawlings
Journal:  EMBO J       Date:  1998-04-01       Impact factor: 11.598

9.  Phosphatidylinositol-3,4,5-trisphosphate (PtdIns-3,4,5-P3)/Tec kinase-dependent calcium signaling pathway: a target for SHIP-mediated inhibitory signals.

Authors:  A M Scharenberg; O El-Hillal; D A Fruman; L O Beitz; Z Li; S Lin; I Gout; L C Cantley; D J Rawlings; J P Kinet
Journal:  EMBO J       Date:  1998-04-01       Impact factor: 11.598

10.  SLP-65: a new signaling component in B lymphocytes which requires expression of the antigen receptor for phosphorylation.

Authors:  J Wienands; J Schweikert; B Wollscheid; H Jumaa; P J Nielsen; M Reth
Journal:  J Exp Med       Date:  1998-08-17       Impact factor: 14.307

View more
  27 in total

1.  Increased numbers of B-1 cells and enhanced responses against TI-2 antigen in mice lacking APS, an adaptor molecule containing PH and SH2 domains.

Authors:  Masanori Iseki; Chiyomi Kubo; Sang-Mo Kwon; Akiko Yamaguchi; Yuki Kataoka; Nobuaki Yoshida; Kiyoshi Takatsu; Satoshi Takaki
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

Review 2.  Dual role of the adaptor protein SLP-65: organizer of signal transduction and tumor suppressor of pre-B cell leukemia.

Authors:  Sebastian Herzog; Bettina Storch; Hassan Jumaa
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 3.  Receptor crosstalk: reprogramming B cell receptor signalling to an alternate pathway results in expression and secretion of the autoimmunity-associated cytokine, osteopontin.

Authors:  T L Rothstein; B Guo
Journal:  J Intern Med       Date:  2009-06       Impact factor: 8.989

4.  BLNK binds active H-Ras to promote B cell receptor-mediated capping and ERK activation.

Authors:  Yasuhiro Imamura; Akihisa Oda; Takashi Katahira; Kenji Bundo; Kelly A Pike; Michael J H Ratcliffe; Daisuke Kitamura
Journal:  J Biol Chem       Date:  2009-02-13       Impact factor: 5.157

5.  SLP-65 phosphorylation dynamics reveals a functional basis for signal integration by receptor-proximal adaptor proteins.

Authors:  Thomas Oellerich; Mads Grønborg; Konstantin Neumann; He-Hsuan Hsiao; Henning Urlaub; Jürgen Wienands
Journal:  Mol Cell Proteomics       Date:  2009-04-16       Impact factor: 5.911

6.  Novel Innate Immune Genes Regulating the Macrophage Response to Gram Positive Bacteria.

Authors:  Scott Alper; Laura A Warg; Lesly De Arras; Brenna R Flatley; Elizabeth J Davidson; Jenni Adams; Keith Smith; Christine L Wohlford-Lenane; Paul B McCray; Brent S Pedersen; David A Schwartz; Ivana V Yang
Journal:  Genetics       Date:  2016-06-29       Impact factor: 4.562

7.  The direct recruitment of BLNK to immunoglobulin alpha couples the B-cell antigen receptor to distal signaling pathways.

Authors:  Shara Kabak; Brian J Skaggs; Michael R Gold; Michael Affolter; Kelly L West; Mark S Foster; Karyn Siemasko; Andrew C Chan; Ruedi Aebersold; Marcus R Clark
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

8.  BLNK suppresses pre-B-cell leukemogenesis through inhibition of JAK3.

Authors:  Joji Nakayama; Mutsumi Yamamoto; Katsuhiko Hayashi; Hitoshi Satoh; Kenji Bundo; Masato Kubo; Ryo Goitsuka; Michael A Farrar; Daisuke Kitamura
Journal:  Blood       Date:  2008-12-01       Impact factor: 22.113

9.  Deficiency of BLNK hampers PLC-gamma2 phosphorylation and Ca2+ influx induced by the pre-B-cell receptor in human pre-B cells.

Authors:  Tomoko Taguchi; Nobutaka Kiyokawa; Hisami Takenouch; Jun Matsui; Wei-Ran Tang; Hideki Nakajima; Kyoko Suzuki; Yusuke Shiozawa; Masahiro Saito; Yohko U Katagiri; Takao Takahashi; Hajime Karasuyama; Yoshinobu Matsuo; Hajime Okita; Junichiro Fujimoto
Journal:  Immunology       Date:  2004-08       Impact factor: 7.397

10.  Pre-B cell receptor-mediated cell cycle arrest in Philadelphia chromosome-positive acute lymphoblastic leukemia requires IKAROS function.

Authors:  Daniel Trageser; Ilaria Iacobucci; Rahul Nahar; Cihangir Duy; Gregor von Levetzow; Lars Klemm; Eugene Park; Wolfgang Schuh; Tanja Gruber; Sebastian Herzog; Yong-mi Kim; Wolf-Karsten Hofmann; Aihong Li; Clelia Tiziana Storlazzi; Hans-Martin Jäck; John Groffen; Giovanni Martinelli; Nora Heisterkamp; Hassan Jumaa; Markus Müschen
Journal:  J Exp Med       Date:  2009-07-20       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.